Bamco Inc. NY Has $57.36 Million Stock Holdings in Masimo Corporation $MASI

Bamco Inc. NY raised its position in Masimo Corporation (NASDAQ:MASI) by 1.1% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 388,747 shares of the medical equipment provider’s stock after buying an additional 4,158 shares during the period. Bamco Inc. NY owned about 0.72% of Masimo worth $57,360,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in MASI. Vanguard Group Inc. lifted its stake in shares of Masimo by 3.7% during the third quarter. Vanguard Group Inc. now owns 4,810,011 shares of the medical equipment provider’s stock valued at $709,717,000 after acquiring an additional 171,876 shares during the period. Massachusetts Financial Services Co. MA increased its position in Masimo by 6.1% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,619,960 shares of the medical equipment provider’s stock worth $386,575,000 after purchasing an additional 149,567 shares during the period. State Street Corp raised its holdings in Masimo by 0.7% during the 2nd quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock worth $250,041,000 after purchasing an additional 10,403 shares during the last quarter. Westfield Capital Management Co. LP raised its holdings in Masimo by 20.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,419,250 shares of the medical equipment provider’s stock worth $209,410,000 after purchasing an additional 238,047 shares during the last quarter. Finally, Durable Capital Partners LP lifted its position in Masimo by 3.4% during the 2nd quarter. Durable Capital Partners LP now owns 1,163,898 shares of the medical equipment provider’s stock valued at $195,791,000 after purchasing an additional 38,279 shares during the period. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Price Performance

Masimo stock opened at $175.49 on Monday. The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.72. The firm has a market capitalization of $9.43 billion, a P/E ratio of -16.65, a PEG ratio of 1.78 and a beta of 1.21. The business has a 50-day moving average of $151.80 and a 200-day moving average of $145.90. Masimo Corporation has a 1 year low of $125.94 and a 1 year high of $175.90.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on MASI shares. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research note on Tuesday, February 17th. Bank of America started coverage on shares of Masimo in a research note on Monday, November 17th. They set a “neutral” rating and a $162.00 price target for the company. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Monday, December 1st. BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Finally, Wells Fargo & Company lowered shares of Masimo from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $190.00 to $180.00 in a report on Wednesday, February 18th. One equities research analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $181.17.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.